AAV-MyoAAV 3A Rep-Cap plasmid (serotype MyoAAV 3A - specific AAV RC-MyoAAV 3A plasmids) (Amp and Kanamycin) (GeneMedi Owned)

GeneMedi's MyoAAV 3A Rep-Cap plasmid supplies the AAV2 Rep (replication) proteins and the MyoAAV 3A capsid protein.

You can produce MyoAAV 3A particle in 293T cell line in high titer using GeneMedi's MyoAAV 3A Rep-Cap plasmid with GM's AAV expression vector (overexpression or shRNA) and AAV helper plasmid.

MyoAAV3A might offer improved transduction rates or a different tissue specificity profile within the muscle tissue spectrum, possibly targeting specific muscle types more effectively than other variants. Adjustments to capsid proteins to enhance binding to muscle cell receptors or to evade immune recognition could characterize this variant.

GeneMedi offers both Ampicillin (Amp) resistance and Kanamycin (Kan) resistance for the AAV Rep-Cap Plasmids.

Target products collectionGo to AAV vector system >>


Product Description

Cat.NO Product Name Organization Type Price(In USD)
P-RC32 AAV-MyoAAV 3A Rep-Cap Plasmid (Amp resistance)
Size:5ug
Academic 2062
P-RC32 AAV-MyoAAV 3A Rep-Cap Plasmid (Amp resistance)
Size:5ug
Biotech & Pharma & Medical Device & Diagnostics
P-RC32 AAV-MyoAAV 3A Rep-Cap Plasmid (Amp resistance)
Size:5ug
CRO&CDMO&
CXO&CMC&
Manufacturing company
P-RC32 AAV-MyoAAV 3A Rep-Cap Plasmid (Amp resistance)
Size:≥10mg
All
P-RC32-Kan AAV-MyoAAV 3A Rep-Cap Plasmid (Kan resistance)
Size:≥10mg
All
P-PK32 AAV-MyoAAV 3A Vector System (Amp resistance)
1. MyoAAV 3A Rep-Cap Plasmid, 5ug
2. AAV Helper Plasmid, 5ug
3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug
Academic 3379
P-PK32 AAV-MyoAAV 3A Vector System (Amp resistance)
1. MyoAAV 3A Rep-Cap Plasmid, 5ug
2. AAV Helper Plasmid, 5ug
3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug
Biotech & Pharma & Medical Device & Diagnostics
P-PK32 AAV-MyoAAV 3A Vector System (Amp resistance)
1. MyoAAV 3A Rep-Cap Plasmid, 5ug
2. AAV Helper Plasmid, 5ug
3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug
CRO&CDMO&
CXO&CMC&
Manufacturing company
P-PK32 AAV-MyoAAV 3A Vector System (Amp resistance)
1. MyoAAV 3A Rep-Cap Plasmid, ≥10mg
2. AAV Helper Plasmid, ≥10mg
3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01-Kan), ≥10mg
All
P-PK32-Kan AAV-MyoAAV 3A Vector System(Kan resistance)
1. MyoAAV 3A Rep-Cap Plasmid(Kan resistance), ≥10mg
2. AAV Helper Plasmid(Kan resistance), ≥10mg
3. pGMAAV-CMV-MCS-T2A-ZsGreen (Kan resistance) (P-AAVV-B01-Kan), ≥10mg
All
GeneMedi offers both seed and amplification services for the Amp-resistant AAV Rep-Cap Plasmid.
GeneMedi only offers amplification services and do not provide seed for the Kan-resistant AAV Rep-Cap Plasmid currently.
If you want to obtain higher quantities of plasmids (mg), please visit GM TransExcellent Plasmid DNA Rapid Preparation Service.
Terms of sale:
For Seed (5ug):
The purchaser may not reverse engineer this product to extract the sequence for independent use. The purchaser may not transfer this product to others for manufacturing purposes. The purchaser may not use this material to manufacture this product for any other party.

For plasmid production& amplification (≥10mg):
The purchaser may not reverse engineer this product to extract the sequence for independent use. The purchaser may not transfer this product to others for manufacturing purposes. The purchaser may not use this material to manufacture this product for themselves or any other party.

Citation

Title Publication Date
Pancreatic acinar cells-derived sphingosine-1-phosphate contributes to fibrosis of chronic pancreatitis via inducing autophagy and activation of pancreatic stellate cells Gastroenterology 2023/8/25
Aerobic glycolysis is the predominant means of glucose metabolism in neuronal somata, which protects against oxidative damage Nature Neuroscience 2023/11/23
ACSS2-dependent histone acetylation improves cognition in mouse model of Alzheimer's disease Molecular Neurodegeneration 2023/7/12
Suppressing Mesenchymal Stromal Cell Ferroptosis Via Targeting a Metabolism-Epigenetics Axis Corrects their Poor Retention and Insufficient Healing Benefits in the Injured Liver Milieu Advanced Science 2023/2/19
Palmitoyltransferase DHHC9 and acyl protein thioesterase APT1 modulate renal fibrosis through regulating β-catenin palmitoylation Nature Communications 2023/10/21
Aryl hydrocarbon receptor is a proviral host factor and a candidate pan-SARS-CoV-2 therapeutic target Science Advances 2023/5/31
Pharmacological manipulation of macrophage autophagy effectively rejuvenates the regenerative potential of biodegrading vascular graft in aging body Bioactive Materials 2021/10/20
Gut microbiota regulates chronic ethanol exposure-induced depressive-like behavior through hippocampal NLRP3-mediated neuroinflammation Molecular Psychiatry 2022/10/24
Targeted m6A Demethylation of ITGA6 mRNA by a Multisite dCasRx–m6A Editor Inhibits Bladder Cancer Development Journal of Advanced Research 2023/3/30
Delineating the dynamic evolution from preneoplasia to invasive lung adenocarcinoma by integrating single-cell RNA sequencing and spatial transcriptomics Experimental & Molecular Medicine 2022/11/25


Validation data

No data found


Associated products and services


Products & Service Products & Service Information
AAV Packaging service Detail
Promise-ORF™ viral CDNA library Detail
Plasmid DNA Rapid Preparation Service Detail